title: IL-4 release by human leukemic and activated normal basophils.
abstract: Recently, authors have addressed the ability of human basophils to produce IL-4. We report here the detection of significant serum IL-4 levels in a case of acute transformation of chronic myelogenous leukemia with a predominant basophilic cell population. Leukemic basophils were isolated from patients' PBMC and assayed for their IL-4-mRNA expression and their ability to secrete this cytokine in vitro. Leukemic basophilic cells (> 90% toluidine blue positive) but not other PBMC expressed IL-4-mRNA, contained IL-4 protein, and secreted this cytokine. These cells had a spontaneous IL-4 secretion ability, without a need for an exogenous activator. Meanwhile, IL-4 release was significantly increased following leukemic cell activation through Fc epsilon RI-ligation or by Ca2+ ionophore. IL-4 and its mRNA were also detected in leukemic basophils from three other chronic myelogenous leukemia patients with moderate basophilia (13, 14, and 23% basophils in PBMC). To confirm these data in normal human cells, we have developed a method to obtain large numbers of purified basophils from human bone marrow cell cultures. In contrast to leukemic basophils, normal cells required in vitro activation through Fc epsilon RI ligation or by Ca2+ ionophore to express and secrete IL-4. Leukemic and normal basophils secreted histamine following in vitro activation, but were negative for tryptase. These data thus demonstrate the in vivo and in vitro ability of human basophils to produce IL-4.
authors.affiliation: Immunology Department, CNRS URA625, Pitié-Salpêtrière Hospital, Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Arock
authors.forename: H
authors.initials: H
authors.lastname: Merle-Béral
authors.forename: B
authors.initials: B
authors.lastname: Dugas
authors.forename: F
authors.initials: F
authors.lastname: Ouaaz
authors.forename: L
authors.initials: L
authors.lastname: Le Goff
authors.forename: I
authors.initials: I
authors.lastname: Vouldoukis
authors.forename: J M
authors.initials: JM
authors.lastname: Mencia-Huerta
authors.forename: C
authors.initials: C
authors.lastname: Schmitt
authors.forename: V
authors.initials: V
authors.lastname: Leblond-Missenard
authors.forename: P
authors.initials: P
authors.lastname: Debre
mesh_terms: D001491:Basophils / Q000166:cytology / Q000276:immunology*; D001854:Bone Marrow Cells; D002469:Cell Separation; D015870:Gene Expression; D006636:Histamine Release; D006801:Humans; D017403:In Situ Hybridization; D015847:Interleukin-4 / Q000378:metabolism*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000378:metabolism* / Q000473:pathology; D012333:RNA, Messenger / Q000235:genetics
chemical_list: D012333:RNA, Messenger; D015847:Interleukin-4